Gide, counsel to Guerbet on the acquisition of Mallinckrodt’s Contrast Media and Delivery Systems business
Gide advises Guerbet, a pioneer in the field of contrast agents for medical imaging, on the acquisition of US leading specialty biopharmaceutical company Mallinckrodt’s Contrast Media and Delivery Systems business (CMDS).
Guerbet is acquiring 100% of the CMDS business, present in nearly 50 countries. The transaction is valued at USD 270 million, and shall be paid in cash and debt financed. It concerns the purchase of companies including production sites, intellectual property rights and distribution subsidiaries in various geographical zones.